Fentanyl, a potent opioid agonist, was developed in the 1950s to fill a need for strong and rapid analgesia. Because of these characteristics, fentanyl is commonly used to treat chronic cancer pain or in anesthesia. Fentanyl is related to other opioids like morphine and oxycodone.
Fentanyl's high potency has also made it a common adulterant in illicit drugs, especially heroin. In 2017, 47600 overdose deaths in the United States involved some opioid (over 2/3 of all overdose deaths). Opioid overdoses kill an average of 11 Canadians daily.
Fentanyl was FDA approved in 1968.
Fentanyl intravenous or intramuscular injections are indicated for short term analgesia during induction, maintenance, and recovery from general or regional anesthesia. These injections are also used with a neuroleptic for premedication, induction, and as an adjunct to maintenance of anesthesia. Finally, fentanyl intravenous or intramuscular injections are used with oxygen for anesthesia in high risk patients.
Fentanyl sublingual tablets, transmucosal lozenges, buccal tablets, sublingual sprays, transdermal systems, and nasal sprays are indicated for the management of breakthrough pain in opioid tolerant cancer patients who require around the clock pain management.
Benha University, Banhā, El Qalyoubia, Egypt
Mohamed Hamed, Fayoum, Egypt
Fayoum University Hospital, Fayoum, Egypt
Medipol Mega University Hospital, Istanbul, Bagcılar, Turkey
Mount Sinai Hospital, Toronto, Ontario, Canada
Aculty of Medicine,Zagazig University, Zagazig, El Sharkia, Egypt
Theodor Bilharz Research Institute, Giza, Egypt
Health Sciences University Gazi Yaşargil Training and Research Hospital, Diyarbakır, Kayapınar, Turkey
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.